EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-4.3%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.81B
AUM Growth
+$135M
(+2.4%)
Cap. Flow
+$429M
Cap. Flow
% of AUM
7.38%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
954
New
28
Increased
196
Reduced
108
Closed
52
Top Buys
| 1 |
Visa
V
|
$50.7M |
| 2 |
PACCAR
PCAR
|
$42.4M |
| 3 |
KLA
KLAC
|
$35.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$35.1M |
| 5 |
Amazon
AMZN
|
$21.8M |
Top Sells
| 1 |
Marriott International Class A Common Stock
MAR
|
$51.9M |
| 2 |
Abbott
ABT
|
$28.5M |
| 3 |
Pfizer
PFE
|
$27.1M |
| 4 |
Viasat
VSAT
|
$18M |
| 5 |
Qualcomm
QCOM
|
$14.1M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 18.76% |
| 3 | Financials | 9.65% |
| 4 | Consumer Discretionary | 9.57% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
276
Marriott International Class A Common Stock
MAR
$71.9B
| $1.94M | 0.03% |
9,700
-260,000
| -96% | -$51.9M |
|
277
Jones Lang LaSalle
JLL
$14.8B
| $1.93M | 0.03% |
13,777
+148
| +1% | +$20.8K |
|
278
Tenaris
TS
$18.2B
| $1.92M | 0.03% |
60,000
| – | – |
|
279
TSMC
TSM
$1.26T
| $1.89M | 0.03% |
21,820
-48,380
| -69% | -$4.18M |
|
280
Halozyme
HALO
$8.76B
| $1.87M | 0.03% |
47,800
| – | – |
|
281
Shopify
SHOP
$191B
| $1.86M | 0.03% |
35,000
| – | – |
|
282
Marathon Petroleum
MPC
$54.8B
| $1.85M | 0.03% |
12,000
| – | – |
|
283
BridgeBio Pharma
BBIO
$10.2B
| $1.85M | 0.03% |
68,225
| – | – |
|
284
Arista Networks
ANET
$180B
| $1.84M | 0.03% |
40,000
| – | – |
|
|
MRO
285
DELISTED
Marathon Oil Corporation
MRO
| $1.84M | 0.03% |
66,955
+891
| +1% | +$24.4K |
|
286
Ascendis Pharma
ASND
$12.5B
| $1.76M | 0.03% |
18,500
| – | – |
|
287
FMC
FMC
$4.72B
| $1.7M | 0.03% |
25,787
-27,186
| -51% | -$1.8M |
|
288
Cognizant
CTSH
$35.1B
| $1.7M | 0.03% |
+25,000
| New | +$1.7M |
|
289
Infosys
INFY
$67.9B
| $1.7M | 0.03% |
100,000
| – | – |
|
290
Hershey
HSY
$37.6B
| $1.68M | 0.03% |
8,318
-19,669
| -70% | -$3.98M |
|
291
Exelixis
EXEL
$10.2B
| $1.67M | 0.03% |
74,500
| – | – |
|
292
Travelers Companies
TRV
$62B
| $1.66M | 0.03% |
9,900
| – | – |
|
293
Idexx Laboratories
IDXX
$51.4B
| $1.61M | 0.03% |
3,690
+450
| +14% | +$197K |
|
|
KRTX
294
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.61M | 0.03% |
9,470
+2,400
| +34% | +$409K |
|
295
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.59M | 0.03% |
3
| – | – |
|
296
Target
TGT
$42.3B
| $1.56M | 0.03% |
14,213
-4,110
| -22% | -$452K |
|
297
Passage Bio
PASG
$22.8M
| $1.55M | 0.03% |
118,040
+10,000
| +9% | +$132K |
|
298
Annaly Capital Management
NLY
$14.2B
| $1.55M | 0.03% |
82,800
| – | – |
|
299
CBRE Group
CBRE
$48.9B
| $1.53M | 0.03% |
20,900
| – | – |
|
300
Aflac
AFL
$57.2B
| $1.53M | 0.03% |
19,700
| – | – |
|